ANEB Anebulo Pharmaceuticals, Inc.
Healthcare · Market cap: $11.4M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $10.0M | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $0 | $0 |
Bought$10.1M5 buy days
Sold$00 sell days
Net insider flow+$10.1Mnet buying · 5 years
Latest trade2024-12-23English Aron R.
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2024-12-23 | Buy | English Aron R. | Director | 10,101,010 | $0.99 | $10.0M | 1 |
| 2021-12-17 | Buy | English Aron R. | Director | 400 | $6.59 | $2.6K | 1 |
| 2021-12-14 | Buy | English Aron R. | Director | 412 | $5.90 | $2.4K | 1 |
| 2021-12-03 | Buy | English Aron R. | Director | 4,500 | $5.93 | $26.7K | 1 |
| 2021-12-02 | Buy | English Aron R. | Director | 13,836 | $5.30 | $73.3K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| English Aron R. | Director | $10.1M | $0 | 2024-12-23 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
No buying cluster has formed at this company.
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.